Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UnitedHealth Group Inc (UNH) vs Vanguard Growth Index Fund ETF (VUG) Price & Performance

UnitedHealth Group IncTrade
Vanguard Growth Index Fund ETFTrade

Price performance (Past 24H)

Key statistics

UnitedHealth Group Inc vs Vanguard Growth Index Fund ETF — how do they compare? UnitedHealth Group Inc trades at $378.22 (market cap $332.96B), while Vanguard Growth Index Fund ETF trades at $91.95 (market cap $384.60B). The key difference: Vanguard Growth Index Fund ETF is the larger of the two by market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Vanguard Growth Index Fund ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold UnitedHealth Group Inc for 97 Days and Vanguard Growth Index Fund ETF for 47 Days on average.

UNHVUG
Market Cap
$332.96B$384.60B
Volume
7,273,7495,662,307
Sector
HealthSector/Thematic
52-Week High
$436.35$92.64
52-Week Low
$259.02$70.00
Typical Hold Time
97 Days47 Days
Enterprise Value
$374.82B—
Dividend Yield
2.5%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $375.98, showing minor daily weakness but maintaining a bullish technical signal. The company reported strong Q2 2026 earnings, beating estimates, and reaffirmed its full-year outlook. Revenue growth remains robust, though net margins have compressed from prior years. Analyst sentiment is overwhelmingly positive, with a consensus price target of $473.89 implying significant upside.

The outlook for UNH is favorable, driven by earnings momentum and strategic initiatives like AI investment. Key risks include regulatory pressures and medical cost trends. The stock presents a compelling opportunity for investors seeking exposure to a leading healthcare company with solid fundamentals and Wall Street support.

Vanguard Growth Index Fund ETF

VUG trades at $92.42, down 0.24% on the day, with a bullish technical outlook supported by moving averages but showing overbought conditions on shorter-term RSI readings. The ETF maintains strong long-term performance credentials with 11-12% average annual returns since 2004, though current concentration in mega-cap tech stocks presents both opportunity and risk. Recent dividend activity shows minimal income generation with a $0.09 distribution scheduled for September 2026.

The growth-focused ETF offers exposure to market-leading companies but faces concentration risk with over 36% in three holdings. Long-term investors benefit from Vanguard's low-cost structure and historical outperformance, though near-term technical indicators suggest potential consolidation. Market sentiment remains positive for buy-and-hold strategies despite recent value stock outperformance in 2026.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

UNH
71% Buy29% Sell
Avg holding period · 97 Days
VUG
97% Buy3% Sell
Avg holding period · 47 Days

Top news

Latest headlines on both assets

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →

About Vanguard Growth Index Fund ETF

VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.

Read more on VUG →